SCHEMBL3347490

SCHEMBL3347490

OCC1CSc2cc(F)cc(-c3ccccc3C(F)(F)F)c2O1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 3/20 0.33
TRPA1 O75762 6/20 0.32
TRPM8 Q7Z2W7 3/20 0.32
TRPV1 Q8NER1 3/20 0.32
CNR2 P34972 2/20 0.31
ATM Q13315 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
CTNNB1 P35222 1/20 0.30
WNT3A P56704 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
ALOX15 P16050 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3341809 0.89 AQP1 (0.40) AQP1HTR2CHSD11B1
SCHEMBL3345421 0.85 AQP1 (0.42) AQP1
SCHEMBL14194637 0.83
SCHEMBL3343338 0.80 AKR1C3 (0.32) TRPA1AKR1C3AKR1C2ALDH1A1
SCHEMBL3342415 0.78 ALDH1A1 (0.32) ALDH1A1CYP3A4CYP2D6CYP2C19HSD11B1
SCHEMBL3347355 0.78 AQP1 (0.54) AQP1
SCHEMBL4226266 0.73 AQP1 (0.59) AQP1TRPA1TRPM8TRPV1ATM
SCHEMBL3345385 0.73 HTR2C (0.34) AQP1TRPA1AKR1C3AKR1C2HTR2C
SCHEMBL3343978 0.73 AQP1 (0.50) AQP1HTR2AHTR2C
SCHEMBL3347640 0.72 AKR1C3 (0.39) AKR1C3AKR1C2ALDH1A1HTTTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2010-06-24 US disclosed
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2010-06-24 US disclosed
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2010-06-24 US disclosed
WO-2008052078-A2 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2008-05-02 WO disclosed
WO-2008052078-A2 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2008-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF HTR2C, HTR3B, HTR1A AQP1 2605/4885TRPA1 576/4885TRPM8 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.